Home » Medical Devices » Europe Endoscopic Submucosal Dissection Market

Europe Endoscopic Submucosal Dissection Market By Type (Knives, Tissue Retractors, Grasp/Clips, Injecting Agents, Others); By Application (Oesophageal Cancer, Stomach Cancer, Colon Cancer, Others); By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
Europe Endoscopic Submucosal Dissection Market Size 2023	USD 381.88 million
Europe Endoscopic Submucosal Dissection Market, CAGR	6.40%
Europe Endoscopic Submucosal Dissection Market Size 2032	USD 682.36 million

Market Overview

The Europe Endoscopic Submucosal Dissection Market is projected to grow from USD 381.88 million in 2023 to USD 682.36 million by 2032, at a compound annual growth rate (CAGR) of 6.40%.

The Europe Endoscopic Submucosal Dissection (ESD) market is driven by the rising prevalence of gastrointestinal disorders, including early-stage gastrointestinal cancers, necessitating advanced minimally invasive treatments. The increasing adoption of ESD procedures over conventional surgical methods due to their precision and reduced recovery times further fuels market growth. Favorable reimbursement policies and heightened awareness among healthcare professionals about the clinical benefits of ESD enhance its adoption across the region. Technological advancements, such as improved endoscopic devices and enhanced visualization tools, are also shaping market dynamics. Key trends include the integration of artificial intelligence in endoscopy to improve diagnostic accuracy and procedural efficiency and a growing focus on training programs for healthcare practitioners to refine their ESD skills. The rising demand for outpatient surgical procedures and the expansion of endoscopic facilities across Europe further contribute to the market’s robust growth trajectory.

The European Endoscopic Submucosal Dissection (ESD) market is characterized by strong competition and regional variation in adoption rates. Western and Northern Europe are the leading regions in ESD adoption due to their advanced healthcare systems, high awareness of minimally invasive treatments, and a growing preference for early-stage cancer detection. Key players such as Olympus Corporation, Boston Scientific, and Medtronic dominate the market with their cutting-edge technologies and comprehensive product portfolios. These companies, alongside other significant players like Fujifilm, CONMED, and Karl Storz, contribute to the market’s growth by offering specialized ESD instruments, including knives, tissue retractors, and injecting agents. With an increasing focus on innovation, these companies are driving improvements in procedural safety, efficacy, and patient outcomes. As healthcare infrastructures in Eastern and Southern Europe continue to advance, there is substantial growth potential for ESD adoption across these regions.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Insights

The Europe Endoscopic Submucosal Dissection (ESD) market was valued at USD 381.88 million in 2023 and is projected to reach USD 682.36 million by 2032, growing at a CAGR of 6.40%.
The increasing prevalence of gastrointestinal cancers, particularly early-stage cancers, is driving demand for minimally invasive treatments like ESD.
Technological advancements in endoscopic devices and techniques are enhancing precision, improving outcomes, and boosting ESD adoption.
The growing preference for minimally invasive procedures, offering faster recovery and reduced pain, is contributing to ESD’s market expansion.
Key players in the market include Olympus Corporation, Boston Scientific, Fujifilm, Medtronic, and CONMED Corporation, which are leading innovations in endoscopic devices.
High costs of equipment and a steep learning curve are restraining the broader adoption of ESD in certain regions.
Western Europe leads the market, with strong healthcare systems and high adoption rates, while Eastern Europe is seeing rapid growth.

Market Drivers

Rising Prevalence of Gastrointestinal Disorders

The increasing incidence of gastrointestinal cancers, particularly in their early stages, has significantly driven the demand for advanced treatments like Endoscopic Submucosal Dissection (ESD) across Europe. For instance, a survey by United European Gastroenterology highlighted that gastrointestinal and liver disorders are responsible for around one million deaths each year across Europe. ESD provides a minimally invasive alternative to traditional surgical procedures, offering precise removal of cancerous tissues while preserving healthy structures. Its advantages, including lower complication rates and quicker recovery, have positioned it as a preferred choice for patients and healthcare providers alike. This growing preference underscores the expanding role of ESD in addressing gastrointestinal disorders effectively.

Advancements in Endoscopic Technologies and Techniques

Continuous innovation in endoscopic technologies has enhanced the efficacy and safety of ESD procedures. The introduction of high-definition endoscopes, advanced cutting and coagulation devices, and specialized instruments has enabled greater precision in dissection and improved patient outcomes. Additionally, the development of supportive techniques, such as submucosal injection solutions and enhanced imaging tools, has facilitated the successful execution of complex ESD procedures. These advancements are not only improving clinical outcomes but also boosting the adoption of ESD among healthcare facilities throughout Europe.

Aging Population and Demand for Minimally Invasive Solutions

Europe’s aging population is increasingly susceptible to gastrointestinal diseases, including cancers, amplifying the need for effective and minimally invasive treatments. For instance, the World Economic Forum reports that the proportion of the population over 80 years old in Europe is set to double by 2050. ESD, with its ability to address early-stage malignancies and benign lesions without requiring extensive surgery, aligns perfectly with the healthcare demands of the elderly demographic. As the aging population continues to grow, the demand for such patient-friendly procedures is expected to rise, further fueling the expansion of the ESD market in the region.

Strong Healthcare Infrastructure and Growing Awareness

The robust healthcare infrastructure in many European countries supports the adoption of advanced procedures like ESD through favorable reimbursement policies. For instance, the European Health Data Space initiative aims to improve health data sharing practices, which can enhance patient care and support the adoption of advanced medical procedures. These policies ensure greater access for patients, promoting widespread adoption. Furthermore, increasing awareness among healthcare providers and patients about the benefits of ESD, such as reduced hospital stays and faster recovery, is driving its acceptance. As patients become more informed and opt for minimally invasive treatments, ESD is becoming a standard approach for managing early-stage gastrointestinal cancers and disorders.

Market Trends

Rising Prevalence of Gastrointestinal Cancers

The increasing incidence of early-stage gastrointestinal cancers, including colorectal and esophageal cancers, is significantly driving the demand for advanced treatments like Endoscopic Submucosal Dissection (ESD). For instance, the European Cancer Information System reports that colorectal cancer is one of the most common cancers in Europe, with significant incidence rates. ESD provides a highly effective, minimally invasive alternative to traditional surgery, enabling precise removal of cancerous tissues while minimizing damage to surrounding structures. Its benefits, such as reduced recovery times and lower complication rates, make it a preferred choice among patients and healthcare providers. This trend reflects a broader shift in the medical community toward early intervention and minimally invasive treatment modalities for gastrointestinal malignancies.

Technological Advancements Enhancing ESD Outcomes

Continuous advancements in endoscopic technologies and techniques are revolutionizing ESD procedures, improving their precision, safety, and effectiveness. For instance, innovations such as high-definition endoscopes, specialized cutting and coagulation devices, and enhanced visualization systems allow healthcare practitioners to perform complex dissections with greater accuracy. Innovations such as high-definition endoscopes, specialized cutting and coagulation devices, and enhanced visualization systems allow healthcare practitioners to perform complex dissections with greater accuracy. These technological breakthroughs are complemented by the development of supportive tools, including improved submucosal injection solutions and real-time imaging technologies, which further streamline ESD procedures. Such innovations not only enhance clinical outcomes but also contribute to the growing acceptance of ESD across Europe’s healthcare landscape.

Aging Population Driving Demand for Minimally Invasive Treatments

Europe’s aging population is contributing to the rising demand for minimally invasive gastrointestinal treatments like ESD. Older adults are more prone to gastrointestinal diseases, including cancers, and require effective yet less physically demanding therapeutic options. ESD addresses these needs by providing a safe, patient-friendly approach for treating early-stage malignancies and benign lesions. As the elderly demographic continues to expand, healthcare systems across Europe are increasingly prioritizing minimally invasive procedures to improve patient outcomes and cater to the specific needs of this population.

Favorable Policies and Growing Awareness Supporting Market Growth

Strong healthcare infrastructure and favorable reimbursement policies in many European countries are pivotal in driving the adoption of advanced endoscopic procedures like ESD. These policies ensure that patients can access cutting-edge treatments without prohibitive costs, encouraging widespread utilization. Additionally, growing awareness among both healthcare professionals and patients about the clinical benefits of ESD such as shorter hospital stays, reduced pain, and quicker recovery times further fuels market growth. As awareness about early detection and minimally invasive solutions continues to rise, ESD is becoming a standard approach for managing gastrointestinal disorders effectively.

Market Challenges Analysis

Technical Complexity and Skill Barriers

Endoscopic Submucosal Dissection (ESD) is a highly technical procedure that demands extensive training and significant experience, posing a steep learning curve for healthcare providers. For instance, a survey by the European Society of Gastrointestinal Endoscopy (ESGE) found that only a small percentage of endoscopists in Europe are proficient in ESD due to the lack of standardized training programs. Proficiency in ESD often requires years of practice and specialized mentorship, which can limit its adoption in regions with fewer trained endoscopists. The lack of standardized training and certification programs across Europe exacerbates this challenge, leading to variations in skill levels among practitioners and potentially impacting patient outcomes. Furthermore, the complexity of the procedure itself, combined with the need for precise execution, can restrict its availability to specialized centers, limiting widespread accessibility. Identifying suitable candidates for ESD is another challenge, as patient selection criteria are not universally standardized, leaving room for debate and inconsistency in its application.

High Costs and Limited Reimbursement Support

The cost of ESD is another significant barrier to its widespread adoption. The procedure requires advanced equipment, including high-definition endoscopes, cutting and coagulation devices, and specialized accessories, all of which contribute to high capital expenditures for healthcare facilities. Additionally, ESD is a time-intensive procedure that demands skilled personnel, further driving up operational costs. In some European countries, reimbursement policies do not fully align with these expenses, hindering the financial viability of ESD for both providers and patients. Budget constraints within certain healthcare systems can further limit accessibility, particularly in regions with less robust funding for advanced medical technologies. While ESD is generally regarded as safe, the procedure carries inherent risks, such as bleeding, perforation, and delayed complications, which may deter both patients and providers. These factors, combined with inconsistent reimbursement policies, underscore the need for systemic improvements to facilitate broader adoption of this advanced treatment modality.

Market Opportunities

Expanding Access Through Technological Advancements

The Europe Endoscopic Submucosal Dissection (ESD) market presents significant opportunities for growth, driven by ongoing technological advancements. Innovations in endoscopic devices, such as high-definition imaging systems, enhanced cutting and coagulation tools, and AI-driven diagnostic aids, are improving the accuracy, safety, and efficiency of ESD procedures. These developments not only enhance clinical outcomes but also reduce the technical barriers associated with the procedure, making it more accessible to healthcare facilities. The integration of telemedicine and remote training platforms offers another avenue for expansion, enabling specialists to mentor practitioners in less developed regions, thereby broadening the availability of ESD. As technology evolves, these advancements are expected to facilitate wider adoption and application of ESD across diverse healthcare settings in Europe.

Rising Focus on Preventive Healthcare and Early Detection

The growing emphasis on preventive healthcare and early cancer detection represents a significant market opportunity for ESD. Governments and healthcare organizations across Europe are increasingly promoting initiatives to identify gastrointestinal disorders and early-stage cancers through advanced screening programs. ESD’s effectiveness in addressing early-stage malignancies aligns with these efforts, positioning it as a critical tool in preventive healthcare strategies. Furthermore, increased investments in healthcare infrastructure, particularly in underserved regions, are expected to bolster the adoption of ESD. As awareness among patients and healthcare providers about the benefits of minimally invasive treatments continues to rise, the demand for ESD is poised to grow, creating a robust pathway for market expansion.

Market Segmentation Analysis:

By Type:

The Europe Endoscopic Submucosal Dissection (ESD) market is segmented by type into knives, tissue retractors, grasp/clips, injecting agents, and others. Knives represent a significant share in this segment, driven by their critical role in precise cutting and dissection during ESD procedures. Technological advancements in knife designs, such as enhanced sharpness and ergonomic handling, have further increased their adoption. Tissue retractors and grasp/clips are essential for ensuring safe and effective procedures by stabilizing tissues and minimizing complications. Injecting agents, used for creating submucosal cushions, are gaining traction due to their ability to enhance procedural safety and accuracy. The “others” category, encompassing specialized tools and accessories, supports various procedural needs, ensuring flexibility in application. The growth in this segment is attributed to continuous innovation and the rising adoption of advanced ESD tools across healthcare facilities.

By Application:

By application, the Europe ESD market is categorized into oesophageal cancer, stomach cancer, colon cancer, and others. Colon cancer represents a significant segment, driven by its high prevalence and the growing emphasis on early detection. ESD is increasingly preferred for treating early-stage colon cancers due to its minimally invasive nature and favorable patient outcomes. Similarly, stomach cancer applications are expanding, supported by advancements in diagnostic endoscopy and rising awareness of gastric cancer screening. Oesophageal cancer, though less prevalent, remains a critical segment due to the growing demand for early intervention treatments. The “others” category includes rare gastrointestinal malignancies and benign lesions that benefit from ESD’s precision and efficacy. Rising awareness, coupled with improved healthcare infrastructure, is expected to drive growth across all application segments.

Segments:

Based on Type:

Knives
Tissue Retractors
Grasp/Clips
Injecting Agents
Others

Based on Application:

Oesophageal Cancer
Stomach Cancer
Colon Cancer
Others

Based on End-User:

Hospitals
Ambulatory Surgical Centers
Specialty Clinics

Based on the Geography:

UK
France
Germany
Italy
Spain
Russia
Belgium
Netherlands
Austria
Sweden
Poland
Denmark
Switzerland
Rest of Europe

Regional Analysis

Western Europe

The largest market share is held by Western Europe, which accounts for approximately 45% of the total market. This region has a well-established healthcare infrastructure, favorable reimbursement policies, and a high rate of early cancer detection, all of which support the widespread adoption of ESD. Key countries such as Germany, France, the UK, and Italy are major contributors, with advanced medical facilities and experienced practitioners driving the demand for minimally invasive treatments. The high prevalence of gastrointestinal cancers, combined with an aging population, is further boosting the market in this region.

Northern Europe

Northern Europe holds a significant share of the ESD market, accounting for around 25%. This region benefits from advanced healthcare systems, cutting-edge medical research, and a strong focus on cancer prevention and early detection. Countries such as Sweden, Denmark, and Finland have been at the forefront of adopting minimally invasive endoscopic procedures like ESD due to their well-established healthcare policies and the presence of specialized endoscopists. The growing emphasis on minimizing hospital stays and improving patient recovery times has made ESD a preferred treatment option for early-stage gastrointestinal cancers. As healthcare budgets continue to increase, the demand for ESD procedures is expected to rise steadily across Northern Europe.

Southern Europe

Southern Europe, accounting for approximately 15% of the European ESD market, is experiencing significant growth. Key markets in this region, including Spain, Italy, and Greece, are seeing increasing adoption of advanced endoscopic procedures, driven by rising healthcare investments and greater awareness of gastrointestinal cancer risks. Southern European countries are focusing on improving access to modern treatment options like ESD, supported by favorable reimbursement policies in many cases. The aging population and the rising burden of gastrointestinal diseases further contribute to the growing demand for minimally invasive treatment options. Although there are some challenges in rural areas, the overall outlook for ESD in Southern Europe remains positive.

Eastern Europe

Eastern Europe represents the smallest market share, around 15%, but it is witnessing rapid growth in the adoption of ESD procedures. Countries like Poland, Hungary, and the Czech Republic are seeing improvements in healthcare infrastructure, leading to increased access to advanced treatments. Although the region faces challenges such as limited healthcare funding and fewer specialized practitioners, the demand for effective and less invasive treatments for gastrointestinal cancers is on the rise. With the growing focus on cancer screening and early detection programs, Eastern Europe is expected to see significant expansion in the ESD market over the coming years. Efforts to improve training and certification for endoscopists are likely to further drive market growth.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

Olympus Corporation
Boston Scientific Corp (Boston Scientific)
Fujifilm Holdings Corp (Fujifilm)
CONMED Corporation
Steris PLC
Ovesco Endoscopy AG
Medtronic
Endoskopie W. Haag KG
Erbe Elektromedizin GmbH
Micro-Tech Endoscopy
Creo Medical
Karl Storz SE & Co. KG
DCC Healthcare
Innova Medica SPA

Competitive Analysis

The European Endoscopic Submucosal Dissection (ESD) market is highly competitive, with key players driving innovation and market growth. Leading companies include Olympus Corporation, Boston Scientific, Fujifilm Holdings Corp, Medtronic, CONMED Corporation, Steris PLC, Ovesco Endoscopy AG, Erbe Elektromedizin GmbH, Micro-Tech Endoscopy, and Karl Storz SE & Co. KG. For instance, Olympus Corporation has recently gained CE approval for three AI-powered endoscopy devices, enhancing their product offerings. These players focus on developing advanced endoscopic technologies, offering a wide range of specialized tools and devices such as knives, tissue retractors, injectors, and coagulation systems that enhance the precision and safety of ESD procedures. Companies in the market are focused on developing advanced endoscopic devices to improve the precision, safety, and efficacy of ESD procedures. These innovations include high-definition endoscopes, specialized cutting and coagulation devices, and tissue retraction systems, which enhance clinical outcomes and make ESD a more attractive option for treating early-stage gastrointestinal cancers. Additionally, market players are emphasizing the development of user-friendly instruments and systems to reduce the steep learning curve associated with ESD procedures. The focus on minimizing patient recovery times and enhancing procedural efficiency has driven the adoption of minimally invasive technologies. Companies are also differentiating themselves by offering integrated solutions, including injectors and grasp/clips for precise tumor dissection and removal. While large companies with diverse product portfolios dominate the market, there is room for niche players specializing in specific ESD tools. The growing demand for ESD procedures, fueled by the increasing prevalence of gastrointestinal cancers, is creating opportunities for both established and emerging players to expand their market share.

Recent Developments

In April 2024, Fujifilm launched Tracmotion, an Endoscopic Submucosal Dissection (ESD) device, at a gastroenterology event. The device, designed for single-operator use, has a 360° rotatable retraction capability, allowing precise tissue manipulation.
In October 2023, Olympus unveiled its latest advancement in gastrointestinal endoscopy by introducing the EVIS X1 system, accompanied by the CF-HQ1100DL/I and GIF-1100 series compatible endoscopes. This next-generation system incorporates Color Enhancement Imaging technology, enhancing image color and texture to improve lesion and polyp visibility during endoscopic screenings.
In January 2023, Fujifilm India introduced two innovative endoscopy solutions: the FushKnife and ClutchCutter. These cutting-edge tools are designed for use with compatible endoscopes, enabling clinicians to perform precise incision, dissection, and coagulation during endoscopic submucosal dissection (ESD) and EMR procedures.

Market Concentration & Characteristics

The market concentration of the Europe Endoscopic Submucosal Dissection (ESD) market is moderately high, with a few large players dominating the space while a growing number of specialized companies contribute to niche segments. Major multinational corporations with robust product portfolios and extensive research capabilities hold a significant share, benefiting from their established presence in the medical device sector. These companies leverage their global distribution networks, strong brand recognition, and continuous innovation to maintain a competitive advantage. On the other hand, smaller, specialized players focus on developing cutting-edge, niche solutions tailored to specific aspects of the ESD procedure, such as advanced endoscopic tools, injectors, and coagulation devices. The market is characterized by rapid technological advancements, with ongoing research and development aimed at improving procedural outcomes, safety, and patient recovery. Additionally, the increasing adoption of minimally invasive procedures is driving the demand for more efficient and effective ESD tools. Regulatory standards and reimbursement policies also play a crucial role in shaping market dynamics, with healthcare systems in Europe striving to maintain cost-effectiveness while ensuring high-quality treatments. The competitive landscape is further influenced by collaborations, partnerships, and acquisitions, as companies seek to expand their product offerings and market reach in response to the growing demand for ESD in Europe.

Report Coverage

The research report offers an in-depth analysis based on Type, Application, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The European Endoscopic Submucosal Dissection (ESD) market is expected to grow significantly due to the increasing prevalence of gastrointestinal cancers.
Technological advancements in endoscopic devices, such as high-definition endoscopes and specialized cutting tools, will drive the adoption of ESD procedures.
The demand for minimally invasive procedures is anticipated to rise, supporting the growth of ESD as a preferred treatment option.
As the aging population in Europe increases, the need for effective and minimally invasive cancer treatment solutions will continue to grow.
Healthcare systems in Europe are likely to increase their focus on adopting advanced endoscopic techniques, driven by cost-effectiveness and patient outcomes.
The development of specialized instruments for ESD, including injectors and tissue retractors, will enhance procedural efficiency and safety.
Growing awareness among healthcare providers and patients about the benefits of ESD will contribute to its wider adoption.
Strong reimbursement policies for advanced endoscopic procedures will support market growth by improving patient access.
Emerging companies will focus on niche innovations, providing more targeted and advanced solutions to specific ESD needs.
The overall outlook for the European ESD market remains positive, with continuous innovation and increasing clinical demand shaping future growth trends.

CHAPTER NO. 1 : INTRODUCTION 21

1.1.1. Report Description 21

Purpose of the Report 21

USP & Key Offerings 21

1.1.2. Key Benefits for Stakeholders 22

1.1.3. Target Audience 22

1.1.4. Report Scope 23

CHAPTER NO. 2 : EXECUTIVE SUMMARY 24

2.1. Europe Endoscopic Submucosal Dissection Market Snapshot 24

2.1.1. Europe Endoscopic Submucosal Dissection Market, 2018 – 2032 (USD Thousand) 25

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 26

3.1. Russia-Ukraine and Israel-Palestine War Impacts 26

CHAPTER NO. 4 : EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET – INDUSTRY ANALYSIS 28

4.1. Introduction 28

4.2. Market Drivers 29

4.2.1. Increasing Incidence of Gastrointestinal Disorders 29

4.2.2. Technological Advancements in Endoscopic Technologies 30

4.2.3. Growing Adoption of Minimally Invasive Procedures 30

4.3. Market Restraints 32

4.3.1. High Cost of Equipment and Procedures 32

4.3.2. Skill and Training Requirements 33

4.3.3. Regulatory Challenges 33

4.4. Market Opportunities 34

4.4.1. Expansion of Indications and Applications 34

4.4.2. Emerging Markets and Untapped Regions 34

4.4.3. Collaborations and Partnerships 35

4.5. Porter’s Five Forces Analysis 37

CHAPTER NO. 5 : ANALYSIS COMPETITIVE LANDSCAPE 38

5.1. Company Market Share Analysis – 2023 38

5.1.1. Europe Endoscopic Submucosal Dissection Market: Company Market Share, by Revenue, 2023 38

5.1.2. Europe Endoscopic Submucosal Dissection Market: Top 6 Company Market Share, by Revenue, 2023 39

5.1.3. Europe Endoscopic Submucosal Dissection Market: Top 3 Company Market Share, by Revenue, 2023 40

5.2. Europe Endoscopic Submucosal Dissection Market Company Revenue Market Share, 2023 41

5.3. Company Assessment Metrics, 2023 42

5.4. Key Players Product Matrix 44

CHAPTER NO. 6 : PESTEL & ADJACENT MARKET ANALYSIS 46

CHAPTER NO. 7 : EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET – BY TYPE SEGMENT ANALYSIS 48

7.1. Europe Endoscopic Submucosal Dissection Market Overview, by Type Segment 48

7.1.1. Europe Endoscopic Submucosal Dissection Market Revenue Share, By Type, 2023 & 2032 48

7.1.2. Europe Endoscopic Submucosal Dissection Market Attractiveness Analysis, By Type 49

7.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 50

7.1.4. Europe Endoscopic Submucosal Dissection Market Revenue, By Type, 2018, 2023, 2027 & 2032 51

7.2. Knives 52

7.3. Tissue Retractors 53

7.4. Grasp/Clips 54

7.5. Injecting Agents 55

7.6. Others 56

CHAPTER NO. 8 : EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET – BY APPLICATION SEGMENT ANALYSIS 57

8.1. Europe Endoscopic Submucosal Dissection Market Overview, by Application Segment 57

8.1.1. Europe Endoscopic Submucosal Dissection Market Revenue Share, By Application, 2023 & 2032 57

8.1.2. Europe Endoscopic Submucosal Dissection Market Attractiveness Analysis, By Application 58

8.1.3. Incremental Revenue Growth Opportunity, by Application, 2024 – 2032 59

8.1.4. Europe Endoscopic Submucosal Dissection Market Revenue, By Application, 2018, 2023, 2027 & 2032 60

8.2. Oesophageal Cancer 61

8.3. Stomach Cancer 62

8.4. Colon Cancer 63

8.5. Others 64

CHAPTER NO. 9 : EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET – BY END-USER SEGMENT ANALYSIS 65

9.1. Europe Endoscopic Submucosal Dissection Market Overview, by End-user Segment 65

9.1.1. Europe Endoscopic Submucosal Dissection Market Revenue Share, By End-user, 2023 & 2032 65

9.1.2. Europe Endoscopic Submucosal Dissection Market Attractiveness Analysis, By End-user 66

9.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 67

9.1.4. Europe Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018, 2023, 2027 & 2032 68

9.2. Hospitals 69

9.3. Ambulatory Surgical Centers 70

9.4. Specialty Clinics 71

CHAPTER NO. 10 : ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET – EUROPE 72

10.1. Europe 72

10.1.1. Key Highlights 73

10.1.2. Europe Endoscopic Submucosal Dissection Market Revenue, By Country, 2018 – 2023 (USD Thousand) 74

10.1.3. Europe Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 76

10.1.4. Europe Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 77

10.1.5. Europe Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 78

10.1. UK 79

10.1.1. UK Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 79

10.1.2. UK Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 80

10.1.3. UK Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 81

10.2. France 82

10.2.1. France Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 82

10.2.2. France Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 83

10.2.3. France Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 84

10.3. Germany 85

10.3.1. Germany Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 85

10.3.2. Germany Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 86

10.3.3. Germany Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 87

10.4. Italy 88

10.4.1. Italy Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 88

10.4.2. Italy Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 89

10.4.3. Italy Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 90

10.5. Spain 91

10.5.1. Spain Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 91

10.5.2. Spain Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 92

10.5.3. Spain Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 93

10.6. Russia 94

10.6.1. Russia Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 94

10.6.2. Russia Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 95

10.6.3. Russia Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 96

10.7. Belgium 97

10.7.1. Belgium Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 97

10.7.2. Belgium Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 98

10.7.3. Belgium Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 99

10.8. Netherland 100

10.8.1. Netherland Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 100

10.8.2. Netherland Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 101

10.8.3. Netherland Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 102

10.9. Austria 103

10.9.1. Austria Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 103

10.9.2. Austria Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 104

10.9.3. Austria Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 105

10.10. Sweden 106

10.10.1. Sweden Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 106

10.10.2. Sweden Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 107

10.10.3. Sweden Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 108

10.11. Poland 109

10.11.1. Poland Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 109

10.11.2. Poland Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 110

10.11.3. Poland Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 111

10.12. Denmark 112

10.12.1. Denmark Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 112

10.12.2. Denmark Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 113

10.12.3. Denmark Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 114

10.13. Switzerland 115

10.13.1. Switzerland Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 115

10.13.2. Switzerland Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 116

10.13.3. Switzerland Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 117

10.14. Rest of Europe 118

10.14.1. Rest of Europe Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 118

10.14.2. Rest of Europe Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 119

10.14.3. Rest of Europe Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 120

CHAPTER NO. 11 : COMPANY PROFILES 121

11.1. Olympus Corporation 121

11.1.1. Company Overview 121

11.1.2. Products Portfolio 122

11.1.3. Financial Overview 123

11.2. Boston Scientific Corp (Boston Scientific) 124

11.2.1. Company Overview 124

11.2.2. Products Portfolio 125

11.2.3. Financial Overview 125

11.3. Fujifilm Holdings Corp (Fujifilm) 125

11.3.1. Company Overview 126

11.3.2. Products Portfolio 127

11.3.3. Financial Overview 128

11.4. CONMED Corporation 129

11.4.1. Company Overview 129

11.4.2. Products Portfolio 130

11.4.3. Financial Overview 130

11.5. Steris PLC 131

11.5.1. Company Overview 131

11.5.2. Products Portfolio 132

11.5.3. Financial Overview 133

11.6. Ovesco Endoscopy AG 134

11.6.1. Company Overview 134

11.6.2. Products Portfolio 134

11.7. Medtronic 135

11.7.1. Company Overview 135

11.7.2. Products Portfolio 137

11.7.3. Financial Overview 137

11.8. Endoskopie W. Haag KG 138

11.8.1. Company Overview 138

11.8.2. Products Portfolio 139

11.9. Erbe Elektromedizin GmbH 140

11.9.1. Company Overview 140

11.9.2. Products Portfolio 141

11.10. Micro-Tech Endoscopy 142

11.10.1. Company Overview 142

11.10.2. Products Portfolio 143

11.11. Creo Medical 144

11.11.1. Company Overview 144

11.11.2. Products Portfolio 145

11.11.3. Financial Overview 145

11.12. Karl Storz SE & Co. KG 146

11.12.1. Company Overview 146

11.12.2. Products Portfolio 146

11.13. DCC Healthcare 147

11.13.1. Company Overview 147

11.13.2. Products Portfolio 148

11.13.3. Financial Overview 148

11.14. Innova Medica SPA 149

11.14.1. Company Overview 149

11.14.2. Products Portfolio 150

CHAPTER NO. 12 : RESEARCH METHODOLOGY 151

12.1. Research Methodology 151

12.1.1. Phase I – Secondary Research 152

12.1.2. Phase II – Data Modeling 152

Company Share Analysis Model 153

Revenue Based Modeling 153

12.1.3. Phase III – Primary Research 154

12.1.4. Research Limitations 155

Assumptions 155

List of Figures

FIG NO. 1. Europe Endoscopic Submucosal Dissection Market Revenue, 2018 – 2032 (USD Thousand) 25

FIG NO. 2. Porter’s Five Forces Analysis for Europe Endoscopic Submucosal Dissection Market 37

FIG NO. 3. Company Share Analysis, 2023 38

FIG NO. 4. Company Share Analysis, 2023 39

FIG NO. 5. Company Share Analysis, 2023 40

FIG NO. 6. Europe Endoscopic Submucosal Dissection Market – Company Revenue Market Share, 2023 41

FIG NO. 7. Company Assessment Metrics, 2023 42

FIG NO. 8. Europe Endoscopic Submucosal Dissection Market Revenue Share, By Type, 2023 & 2032 48

FIG NO. 9. Market Attractiveness Analysis, By Type 49

FIG NO. 10. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 50

FIG NO. 11. Europe Endoscopic Submucosal Dissection Market Revenue, By Type, 2018, 2023, 2027 & 2032 51

FIG NO. 12. Europe Endoscopic Submucosal Dissection Market for Knives, Revenue (USD Thousand) 2018 – 2032 52

FIG NO. 13. Europe Endoscopic Submucosal Dissection Market for Tissue Retractors, Revenue (USD Thousand) 2018 – 2032 53

FIG NO. 14. Europe Endoscopic Submucosal Dissection Market for Grasp/Clips, Revenue (USD Thousand) 2018 – 2032 54

FIG NO. 15. Europe Endoscopic Submucosal Dissection Market for Injecting Agents, Revenue (USD Thousand) 2018 – 2032 55

FIG NO. 16. Europe Endoscopic Submucosal Dissection Market for Others, Revenue (USD Thousand) 2018 – 2032 56

FIG NO. 17. Europe Endoscopic Submucosal Dissection Market Revenue Share, By Application, 2023 & 2032 57

FIG NO. 18. Market Attractiveness Analysis, By Application 58

FIG NO. 19. Incremental Revenue Growth Opportunity by Application, 2024 – 2032 59

FIG NO. 20. Europe Endoscopic Submucosal Dissection Market Revenue, By Application, 2018, 2023, 2027 & 2032 60

FIG NO. 21. Europe Endoscopic Submucosal Dissection Market for Oesophageal Cancer, Revenue (USD Thousand) 2018 – 2032 61

FIG NO. 22. Europe Endoscopic Submucosal Dissection Market for Stomach Cancer, Revenue (USD Thousand) 2018 – 2032 62

FIG NO. 23. Europe Endoscopic Submucosal Dissection Market for Colon Cancer, Revenue (USD Thousand) 2018 – 2032 63

FIG NO. 24. Europe Endoscopic Submucosal Dissection Market for Others, Revenue (USD Thousand) 2018 – 2032 64

FIG NO. 25. Europe Endoscopic Submucosal Dissection Market Revenue Share, By End-user, 2023 & 2032 65

FIG NO. 26. Market Attractiveness Analysis, By End-user 66

FIG NO. 27. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 67

FIG NO. 28. Europe Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018, 2023, 2027 & 2032 68

FIG NO. 29. Europe Endoscopic Submucosal Dissection Market for Hospitals, Revenue (USD Thousand) 2018 – 2032 69

FIG NO. 30. Europe Endoscopic Submucosal Dissection Market for Ambulatory Surgical Centers, Revenue (USD Thousand) 2018 – 2032 70

FIG NO. 31. Europe Endoscopic Submucosal Dissection Market for Specialty Clinics, Revenue (USD Thousand) 2018 – 2032 71

FIG NO. 32. Europe Endoscopic Submucosal Dissection Market Revenue, 2018 – 2032 (USD Thousand) 72

FIG NO. 33. Research Methodology – Detailed View 151

FIG NO. 34. Research Methodology 152

List of Tables

TABLE NO. 1. : Europe Endoscopic Submucosal Dissection Market: Snapshot 24

TABLE NO. 2. : Drivers for the Europe Endoscopic Submucosal Dissection Market: Impact Analysis 29

TABLE NO. 3. : Restraints for the Europe Endoscopic Submucosal Dissection Market: Impact Analysis 32

TABLE NO. 4. : Europe Endoscopic Submucosal Dissection Market Revenue, By Country, 2018 – 2023 (USD Thousand) 74

TABLE NO. 5. : Europe Endoscopic Submucosal Dissection Market Revenue, By Country, 2024 – 2032 (USD Thousand) 75

TABLE NO. 6. : Europe Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 76

TABLE NO. 7. : Europe Endoscopic Submucosal Dissection Market Revenue, By Type, 2024 – 2032 (USD Thousand) 76

TABLE NO. 8. : Europe Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 77

TABLE NO. 9. : Europe Endoscopic Submucosal Dissection Market Revenue, By Application, 2024 – 2032 (USD Thousand) 77

TABLE NO. 10. : Europe Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 78

TABLE NO. 11. : Europe Endoscopic Submucosal Dissection Market Revenue, By End-user, 2024 – 2032 (USD Thousand) 78

TABLE NO. 12. : UK Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 79

TABLE NO. 13. : UK Endoscopic Submucosal Dissection Market Revenue, By Type, 2024 – 2032 (USD Thousand) 79

TABLE NO. 14. : UK Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 80

TABLE NO. 15. : UK Endoscopic Submucosal Dissection Market Revenue, By Application, 2024 – 2032 (USD Thousand) 80

TABLE NO. 16. : UK Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 81

TABLE NO. 17. : UK Endoscopic Submucosal Dissection Market Revenue, By End-user, 2024 – 2032 (USD Thousand) 81

TABLE NO. 18. : France Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 82

TABLE NO. 19. : France Endoscopic Submucosal Dissection Market Revenue, By Type, 2024 – 2032 (USD Thousand) 82

TABLE NO. 20. : France Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 83

TABLE NO. 21. : France Endoscopic Submucosal Dissection Market Revenue, By Application, 2024 – 2032 (USD Thousand) 83

TABLE NO. 22. : France Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 84

TABLE NO. 23. : France Endoscopic Submucosal Dissection Market Revenue, By End-user, 2024 – 2032 (USD Thousand) 84

TABLE NO. 24. : Germany Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 85

TABLE NO. 25. : Germany Endoscopic Submucosal Dissection Market Revenue, By Type, 2024 – 2032 (USD Thousand) 85

TABLE NO. 26. : Germany Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 86

TABLE NO. 27. : Germany Endoscopic Submucosal Dissection Market Revenue, By Application, 2024 – 2032 (USD Thousand) 86

TABLE NO. 28. : Germany Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 87

TABLE NO. 29. : Germany Endoscopic Submucosal Dissection Market Revenue, By End-user, 2024 – 2032 (USD Thousand) 87

TABLE NO. 30. : Italy Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 88

TABLE NO. 31. : Italy Endoscopic Submucosal Dissection Market Revenue, By Type, 2024 – 2032 (USD Thousand) 88

TABLE NO. 32. : Italy Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 89

TABLE NO. 33. : Italy Endoscopic Submucosal Dissection Market Revenue, By Application, 2024 – 2032 (USD Thousand) 89

TABLE NO. 34. : Italy Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 90

TABLE NO. 35. : Italy Endoscopic Submucosal Dissection Market Revenue, By End-user, 2024 – 2032 (USD Thousand) 90

TABLE NO. 36. : Spain Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 91

TABLE NO. 37. : Spain Endoscopic Submucosal Dissection Market Revenue, By Type, 2024 – 2032 (USD Thousand) 91

TABLE NO. 38. : Spain Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 92

TABLE NO. 39. : Spain Endoscopic Submucosal Dissection Market Revenue, By Application, 2024 – 2032 (USD Thousand) 92

TABLE NO. 40. : Spain Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 93

TABLE NO. 41. : Spain Endoscopic Submucosal Dissection Market Revenue, By End-user, 2024 – 2032 (USD Thousand) 93

TABLE NO. 42. : Russia Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 94

TABLE NO. 43. : Russia Endoscopic Submucosal Dissection Market Revenue, By Type, 2024 – 2032 (USD Thousand) 94

TABLE NO. 44. : Russia Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 95

TABLE NO. 45. : Russia Endoscopic Submucosal Dissection Market Revenue, By Application, 2024 – 2032 (USD Thousand) 95

TABLE NO. 46. : Russia Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 96

TABLE NO. 47. : Russia Endoscopic Submucosal Dissection Market Revenue, By End-user, 2024 – 2032 (USD Thousand) 96

TABLE NO. 48. : Belgium Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 97

TABLE NO. 49. : Belgium Endoscopic Submucosal Dissection Market Revenue, By Type, 2024 – 2032 (USD Thousand) 97

TABLE NO. 50. : Belgium Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 98

TABLE NO. 51. : Belgium Endoscopic Submucosal Dissection Market Revenue, By Application, 2024 – 2032 (USD Thousand) 98

TABLE NO. 52. : Belgium Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 99

TABLE NO. 53. : Belgium Endoscopic Submucosal Dissection Market Revenue, By End-user, 2024 – 2032 (USD Thousand) 99

TABLE NO. 54. : Netherland Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 100

TABLE NO. 55. : Netherland Endoscopic Submucosal Dissection Market Revenue, By Type, 2024 – 2032 (USD Thousand) 100

TABLE NO. 56. : Netherland Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 101

TABLE NO. 57. : Netherland Endoscopic Submucosal Dissection Market Revenue, By Application, 2024 – 2032 (USD Thousand) 101

TABLE NO. 58. : Netherland Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 102

TABLE NO. 59. : Netherland Endoscopic Submucosal Dissection Market Revenue, By End-user, 2024 – 2032 (USD Thousand) 102

TABLE NO. 60. : Austria Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 103

TABLE NO. 61. : Austria Endoscopic Submucosal Dissection Market Revenue, By Type, 2024 – 2032 (USD Thousand) 103

TABLE NO. 62. : Austria Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 104

TABLE NO. 63. : Austria Endoscopic Submucosal Dissection Market Revenue, By Application, 2024 – 2032 (USD Thousand) 104

TABLE NO. 64. : Austria Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 105

TABLE NO. 65. : Austria Endoscopic Submucosal Dissection Market Revenue, By End-user, 2024 – 2032 (USD Thousand) 105

TABLE NO. 66. : Sweden Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 106

TABLE NO. 67. : Sweden Endoscopic Submucosal Dissection Market Revenue, By Type, 2024 – 2032 (USD Thousand) 106

TABLE NO. 68. : Sweden Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 107

TABLE NO. 69. : Sweden Endoscopic Submucosal Dissection Market Revenue, By Application, 2024 – 2032 (USD Thousand) 107

TABLE NO. 70. : Sweden Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 108

TABLE NO. 71. : Sweden Endoscopic Submucosal Dissection Market Revenue, By End-user, 2024 – 2032 (USD Thousand) 108

TABLE NO. 72. : Poland Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 109

TABLE NO. 73. : Poland Endoscopic Submucosal Dissection Market Revenue, By Type, 2024 – 2032 (USD Thousand) 109

TABLE NO. 74. : Poland Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 110

TABLE NO. 75. : Poland Endoscopic Submucosal Dissection Market Revenue, By Application, 2024 – 2032 (USD Thousand) 110

TABLE NO. 76. : Poland Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 111

TABLE NO. 77. : Poland Endoscopic Submucosal Dissection Market Revenue, By End-user, 2024 – 2032 (USD Thousand) 111

TABLE NO. 78. : Denmark Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 112

TABLE NO. 79. : Denmark Endoscopic Submucosal Dissection Market Revenue, By Type, 2024 – 2032 (USD Thousand) 112

TABLE NO. 80. : Denmark Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 113

TABLE NO. 81. : Denmark Endoscopic Submucosal Dissection Market Revenue, By Application, 2024 – 2032 (USD Thousand) 113

TABLE NO. 82. : Denmark Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 114

TABLE NO. 83. : Denmark Endoscopic Submucosal Dissection Market Revenue, By End-user, 2024 – 2032 (USD Thousand) 114

TABLE NO. 84. : Switzerland Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 115

TABLE NO. 85. : Switzerland Endoscopic Submucosal Dissection Market Revenue, By Type, 2024 – 2032 (USD Thousand) 115

TABLE NO. 86. : Switzerland Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 116

TABLE NO. 87. : Switzerland Endoscopic Submucosal Dissection Market Revenue, By Application, 2024 – 2032 (USD Thousand) 116

TABLE NO. 88. : Switzerland Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 117

TABLE NO. 89. : Switzerland Endoscopic Submucosal Dissection Market Revenue, By End-user, 2024 – 2032 (USD Thousand) 117

TABLE NO. 90. : Rest of Europe Endoscopic Submucosal Dissection Market Revenue, By Type, 2018 – 2023 (USD Thousand) 118

TABLE NO. 91. : Rest of Europe Endoscopic Submucosal Dissection Market Revenue, By Type, 2024 – 2032 (USD Thousand) 118

TABLE NO. 92. : Rest of Europe Endoscopic Submucosal Dissection Market Revenue, By Application, 2018 – 2023 (USD Thousand) 119

TABLE NO. 93. : Rest of Europe Endoscopic Submucosal Dissection Market Revenue, By Application, 2024 – 2032 (USD Thousand) 119

TABLE NO. 94. : Rest of Europe Endoscopic Submucosal Dissection Market Revenue, By End-user, 2018 – 2023 (USD Thousand) 120

TABLE NO. 95. : Rest of Europe Endoscopic Submucosal Dissection Market Revenue, By End-user, 2024 – 2032 (USD Thousand) 120

Frequently Asked Questions

What is the current size of the Europe Endoscopic Submucosal Dissection market?

The Europe Endoscopic Submucosal Dissection (ESD) market was valued at USD 381.88 million in 2023 and is projected to reach USD 682.36 million by 2032, growing at a compound annual growth rate (CAGR) of 6.40%.

What factors are driving the growth of the Europe Endoscopic Submucosal Dissection market?

The market growth is driven by the rising prevalence of gastrointestinal cancers, advancements in endoscopic technologies, increasing preference for minimally invasive procedures, and the aging population in Europe. Favorable reimbursement policies and growing awareness among healthcare professionals also contribute to the market’s expansion.

What are the key segments within the Europe Endoscopic Submucosal Dissection market?

The key segments include Type (Knives, Tissue Retractors, Grasp/Clips, Injecting Agents, and Others), Application (Oesophageal Cancer, Stomach Cancer, Colon Cancer, and Others), and End-User (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics).

What are some challenges faced by the Europe Endoscopic Submucosal Dissection market?

Challenges include the high technical complexity and steep learning curve for ESD procedures, high costs of equipment, inconsistent reimbursement support across regions, and limited access to trained professionals in certain areas of Europe.

Who are the major players in the Europe Endoscopic Submucosal Dissection market?

Major players include Olympus Corporation, Boston Scientific Corp, Fujifilm Holdings Corp, Medtronic, CONMED Corporation, Steris PLC, Ovesco Endoscopy AG, Erbe Elektromedizin GmbH, Micro-Tech Endoscopy, Karl Storz SE & Co. KG, and Creo Medical. These companies are at the forefront of developing advanced endoscopic devices and tools for ESD procedures.

Purchase Options

Single User

$3699

Multi User

$4699

Custom Report

$6699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –